Northpointe Capital’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-74,850
Closed -$4.46M 186
2015
Q2
$4.46M Buy
74,850
+12,245
+20% +$823K 0.52% 63
2015
Q1
$4.88M Sell
62,605
-15,641
-20% -$1.21M 0.53% 59
2014
Q4
$6.06M Sell
78,246
-40,911
-34% -$2.67M 0.73% 38
2014
Q3
$7.59M Buy
119,157
+11,220
+10% +$763K 0.81% 45
2014
Q2
$7.76M Buy
107,937
+14,017
+15% +$1.08M 0.75% 53
2014
Q1
$8.3M Buy
+93,920
New +$7.31M 0.84% 49

Other funds holding HHS

Northpointe Capital's HHS Position: Q3 2015 in Review

Northpointe Capital sold out of Harte-Hanks (HHS) in Q3 2015, closing a stake of 74,850 shares — an estimated $4.46M sold.

Northpointe Capital first reported a position in HHS in Q1 2014 and held it in 6 quarters. The position peaked at $8.3M in Q1 2014. 125 funds tracked by Wall St. Rank hold HHS as of Q3 2015.

  • Northpointe Capital reported no remaining Harte-Hanks position as of Q3 2015 after selling out during the quarter.
  • Northpointe Capital sold 74,850 Harte-Hanks shares in Q3 2015, an estimated $4.46M.
  • Northpointe Capital first reported a position in Harte-Hanks in Q1 2014 and held it in 6 quarters.
  • Northpointe Capital's Harte-Hanks position peaked at $8.3M in Q1 2014.
  • 125 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2015.

Based on Northpointe Capital's 13F filing for Q3 2015, filed 27 Oct 2015.